Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-09-02 17:38:13 ET · period of report 2026-08-31 · accession 0001989533-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-02 17:38 | 2026-08-31 | JAZZ | Henderson Mary Elizabeth | SVP, Technical Ops | F - Tax | $241.41 | -2,092 | 25.2K | -8% | -$505.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-31 | F | D | 2,076 | $241.39 | 25,258 | D | — | — | (F1) Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
| 2 | Common | Ordinary Shares | 2026-08-31 | F | D | 16 | $244.64 | 25,242 | D | — | — | (F1) Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |